Skip to main content

Table 4 Comparison of the clinical and pulmonary findings between patients with and without MPNST

From: Structural alteration of lung parenchyma in patients with NF1: a phenotyping study using multidetector computed tomography (MDCT)

 

MPNST

n = 30

No MPNST

n = 41

p valuea

Female gender

12 (40)

28 (68)

< 0.05

Age

36 ± 13

32 ± 15

0.26

Current Smokers

9 (30)

8 (20)

0.46

Reticulations

10 (33)

8 (20)

0.30

Nodules

17 (57)

6 (15)

< 0.001

≤ 10

12 (40)

6 (15)

< 0.05

> 10

5 (17)

0 (0)

< 0.05

Ø Diameter (mm)

5 ± 2

4 ± 2

0.23

GGO

4 (14)

3 (7)

0.42

Consolidation

3 (11)

3 (7)

0.67

Emphysema

11 (37)

11 (27)

0.53

 Centrilobular

2 (7)

3 (7)

1.0

 Paraseptal

11 (37)

10 (24)

0.39

Cysts

10 (33)

15 (37)

0.97

≤ 10

8 (27)

10 (24)

0.95

> 10

2 (7)

5 (12)

0.69

Ø Diameter (mm)

8 ± 2

7 ± 4

0.59

UL

6 (20)

8 (20)

0.80

ML

1 (3)

1 (2)

1.0

LL

3 (10)

6 (15)

0.72

Thickened interlobular septa

5 (17)

5 (12)

0.73

Pleural effusion

2 (7)

1 (2)

0.57

Pulmonary metastasis

6 (21)

0 (0)

< 0.05

  1. Data are presented as absolute numbers and frequencies (%) or as mean values ± standard deviation (SD)
  2. aFisher exact test or χ2 test; p values < 0.05 (bold) were considered to indicate statistical significance
  3. MPNST malignant peripheral nerve sheath tumor, GGO ground glass opacity, UL upper lobe, ML middle lobe, LL lower lobe